IP Library › Granted Patent US 8,242,171
Granted Patent B2
US 8,242,171 · App. 12/683,998 · Granted Aug 14, 2012

Method for reducing the weight of a subject or inhibiting weight gain in a subject

Assignees: President and Fellows of Harvard College; The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,242,171
App. No.
12/683,998
Granted
Aug 14, 2012
Kind
B2
Abstract

Provided herein are methods and compositions for modulating the activity or level of a sirtuin, thereby treating or preventing obesity or an insulin resistance disorder, such as diabetes in a subject. Exemplary methods comprise contacting a cell with a sirtuin activating compound or an inhibitory compound to thereby increase or decrease fat accumulation, respectively.

Claims (4)

1. A method for reducing the weight of a subject, or inhibiting weight gain in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition consisting essentially of resveratrol.

2. The method of claim 1 , wherein the pharmaceutical composition comprises one or more pharmaceutically acceptable carriers.

3. The method of claim 2 , wherein the one or more pharmaceutically acceptable carriers is/are one or more liquid or solid fillers, diluents, excipients, solvents or encapsulating materials selected from the group consisting of: sugars, optionally lactose, glucose and/or sucrose; starches, optionally corn starch and/or potato starch; cellulose, and its derivatives, optionally sodium carboxymethyl cellulose, ethyl cellulose and/or cellulose acetate; powdered tragacanth; malt; gelatin; talc; excipients, optionally cocoa butter and/or suppository waxes; oils, optionally peanut oil, cottonseed oil, safflower oil, sesame oil, olive oil, corn oil and/or soybean oil; glycols, optionally propylene glycol; polyols, optionally glycerin, sorbitol, mannitol and/or polyethylene glycol; esters, optionally ethyl oleate and/or ethyl laurate; agar; buffering agents, optionally magnesium hydroxide and/or aluminum hydroxide; alginic acid; pyrogen-free water; isotonic saline; Ringer's solution; and phosphate buffer solutions.

4. The method of claim 1 , wherein the resveratrol is not in a form that is naturally-occurring.

Continuity (4)
Continuation 11027779 · Dec 29, 2004
Provisional Application 60588643 · Jul 16, 2004
Provisional Application 60533712 · Dec 29, 2003
Related Publication 20100316679A1 · Dec 16, 2010